Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex
Cmo se administra el medicamento retatrutida
(December 2009)
This work enhances the interpretability of vMRI measures, advances understanding of HD progression, and supports the use of vMRI as an imaging biomarker for drug development Other authorsSee publication Safety and Efficacy of Flexible-dose Deutetrabenazine in Children and Adolescents with Tourette Syndrome: A Randomized Clinical Trial (ARTISTS 1) JAMA Open Network In this randomized, double-blind, placebo-controlled study of deutetrabenazine in children and adolescents with Tourette syndrome, the primary efficacy end point was not met
doi:10.1016/b978-0-12-079035-7.50015-4
US$ 29.43
US$ 25.57
US$ 24.14
US$ 29.04
US$ 26.67
US$ 28.12
US$ 29.95
US$ 22.23
US$ 22.33
US$ 26.44
US$ 23.72
